Dr. Diana Bolotin, MD

Dr. Bolotin practices at The University of Chicago Medical Center in Chicago, Illinois.

Dr. Bolotin's NPI, 1164746905, was assigned on March 23, 2010. Dr. Bolotin graduated from University of Chicago, Pritzker School of Medicine in 2006. Dr. Bolotin holds Illinois license 036.125194.

Dr. Bolotin's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Dr. Bolotin's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Dr. Bolotin is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Dr. Bolotin to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bolotin practices. Vendor and product names are available with a free account.

Dermatology is Dr. Bolotin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bolotin is licensed in Illinois.

CMS data shows 426 Medicare services from Dr. Bolotin across 12 procedure codes in 2024, for 194 Medicare patients. Medicare paid $66,380 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 194 Medicare patients who saw Dr. Bolotin in 2024. The largest group is 65 to 74, with 88 patients. 71% of them have high blood pressure, and 62% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bolotin's median patient age at 73, with 47% women.

In 2024, Dr. Bolotin wrote 89 Medicare Part D claims for 60 patients. 100% of them were for generic drugs. CMS names the drug for 85 of them, across 3 drugs with 11 or more claims each, at $396 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

Dr. Bolotin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 60 procedures of melanoma (skin cancer) excision by Dr. Bolotin, more than 88% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 37 papers to Dr. Bolotin, published from 2012 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Skin Neoplasms, Carcinoma, Squamous Cell and Mohs Surgery. Dr. Bolotin has published most often in Arch Dermatol Res. Dr. Bolotin's most frequent co-authors are Ian A. Maher, MD, Kira Minkis, MD, PhD and Todd Vincent Cartee, MD.

Dmand AI links Dr. Bolotin to 1 clinical trial. Conditions studied include Basal Cell Nevus Syndrome and Jaw Cysts. Open Payments lists research payments to Dr. Bolotin that name 1 trial.

CMS Open Payments shows 4 general payments to Dr. Bolotin from 2 drug and device companies from 2018 to 2019. Consulting fees make up the largest share, 91% of the total. Abbvie Inc. paid the most, $1,862. It also lists 7 research payments totaling $1,074 from 2024 to 2025, naming 1 clinical trial.

Dr. Bolotin graduated from University of Chicago, Pritzker School of Medicine in 2006.